Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, December 20, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Vetter Development Service Chicago is Now Ready for Realizing Clinical Syringe Projects
Friday, December 12, 2014
Recent facility expansion offers new manufacturing options and additional filling capacity.

Studying Dissolved Gases in Aqueous Solution
Tuesday, December 09, 2014
HPR-40 mass spectrometer series from Hiden for monitoring dissolved gaseous content.

Horizon Launches Gene-Engineered Bioproduction Cell Line
Tuesday, December 09, 2014
Precisely engineered cell line will facilitate a new revenue stream and enable faster, more efficient production of therapeutic antibodies.

Quick Evaluation with New UNICORN™ 7.0 Software
Wednesday, November 26, 2014
The software controls protein purification runs as well as cell culture and preparation.

New Whitepaper from Malvern Instruments
Friday, November 21, 2014
Explores how Malvern extends a QbD approach to instrument design.

Merck Millipore Launches Kit for Analyzing NF?B Translocation
Thursday, November 20, 2014
Permits quantitative, statistically robust assessment of NF?B translocation.

New ambr® 15 Webinar on Overcoming Bottlenecks in Cell Line Development
Wednesday, November 19, 2014
Features data showing how this technology can improve biologics manufacturing.

Agilent Introduces New Column Innovations for Biotherapeutics Development
Thursday, November 13, 2014
Reversed-phase columns optimized to separate monoclonal antibodies.

BioCision Announces Industry’s First Automated Biospecimen Thawing System
Wednesday, November 12, 2014
Intelligent device utilizes adaptive sensing technology for accurate and standardized thawing.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 493
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn